Sixty-percent of prostate cancer cases occur in men over the age of 65. The mean age of prostate cancer patients is 66. It can afflict those under 40, but that is uncommon.
Former Presidential Candidate and possible candidate for Senator from Utah Mitt Romney was 70 when he was diagnosed. Last year Romney underwent surgery to remove a tumor from his prostate. John Kerry was diagnosed while running for president in 2002.
After undergoing his surgery at California’s UC Irvine Hospital Mitt Romney’s chances of recovery are described as “good”. Romney was one of 161,360 men diagnosed with prostate cancer last year. This year, the American Cancer Society projects that the number of diagnoses will increase by 3,330 cases.
Dr. David Samadi is a board-certified urologic oncologist. Educated at SUNY Stony Brook Dr. Samadi received additional training at Montefiore Medical Center, Albert Einstein College of Medicine, and Henri Mondor Hospital Creteil.
Dr. Samadi is Currently Chief of Robotic Surgery and Chairman of Urology at Lenox Hill Hospital in NYC. Over the last 10 years, he has had a 90% success rate treating all types of urological cancers. His average yearly caseload is 700 plus patients.
When prostate cancer is diagnosed the patient is presented with two treatment options, surgery or radiation. If the former is chosen Dr. David Samadi has a list of things that the patient should ask their surgeon about. His/her surgical success rate and the number of cases of recurring cancer among the surgeon’s patients. Also, ask about the rate of post-surgical urinary incontinence and sexual dysfunction.
Before the patient chooses a course of treatment Dr. Samadi has a discussion with them about the benefits and risks of surgery vs. radiation. Dr. Samadi believes surgery is generally the better option if the cancer is contained to the prostate.
Radiation patients are twice as likely to die from prostate cancer as surgical patients. Those who undergo surgery tend to outlive those who undergo radiation treatment live 1.5 times longer. The rate of survival among prostate surgery patients is 100%.
Radiation treatment can lead to a patient developing cancer in another area such as the rectum or bladder. Cancer that recurs after radiation is difficult to treat surgically. Radiation patients who have cancer in an area other than the prostate at the time of treatment have a lower than 30% chance of living another five years after treatment.
Dr. David Samadi’s Facebook Page: www.facebook.com/DrDavidSamadi/